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Objective: To study effect of overexpression of hypoxia-inducible factor-1a induced by
hyperoxia in vivo in LNCaP tumors on tumor growth rate.
Methods: The prostate cancer LNCaP cells were inoculated in the abdomen of mice. All
the mice were randomly placed in the gas chamber with different oxygen content. The
groups were divided as follows: twelve mice in hypoxia group, sixteen mice in normoxia
group, ten mice in hyperoxia group. After 28 d of treatment, the mice were weighed, the
blood samples were taken from the left ventricle, and the tumor was isolated and
weighed. Tumor growth, angiogenesis and vascularization, HIF-1a expression and
intracellular signal transduction molecules expression in each group of xenografts were
detected and analyzed by using Western blotting and immunoﬂuorescence and determi-
nation of hemoglobin.
Results: Comparison of the growth of xenografts in each group showed that, the xe-
nografts growth of hypoxia group was more quickly than that of normoxia group. The
difference was statistically signiﬁcant (P = 0.004). The difference in xenografts growth
between hyperoxia group compared and normoxia group was not statistically signiﬁcant
(P > 0.05). The expressions of HIF-1a, VEGF and VEGF-R of xenografts in hyperoxia
group were signiﬁcantly higher than those of normoxia group (P < 0.05). The expression
of HIF-1a of xenografts in hypoxia group and normoxia group were similar. The blood
growth rate of xenografts in hypoxia group (170%) was signiﬁcantly higher than that of
normoxia group (40%) (P < 0.05). The expression of Nrf2 of xenografts in hyperoxia
group was signiﬁcantly higher than that of normoxia group (P < 0.05).
Conclusions: When hyperoxia induces the overexpression of HIF-1a in LNCaP tumor, it
will not affect tumor growth. It provides a new ideas and theoretical basis for the clinical
treatment of prostate cancer.
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D1. Introduction
Hypoxia is the main cause of malignant solid tumor chemo-
therapy and radiotherapy resistance [1]. When the speed of tumor
proliferation was faster than the speed of oxygen supply by
R capillary network, a hypoxia microenvironment probably
formed in the tumor cell, therefore activate the self-adaptive
mechanism to have more resistance to antagonistic environ-
ment, which probably transfer to the apoptosis process of a rapid
cell growth inhibition [2–5]. In-vitro studies have shown that
hypoxia-inducible factor-1a (HIF-1a) overexpression to regu-
late and adapt to hypoxia was based on the activation of oxygen
sensor of downstream gene, which made the hypoxia microen-
vironment survive [6–8]. By decrease of oxygen inhale to increase
the extent of tumor cell hypoxia will induce moderate systematic
hypoxia, which will result the growth rate of prostate xenografts
LNCaP increased nearly doubled [9]. But when tumor is lack of
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xenografts grew in the alternative pathway of non-HIF-1a
centered [10]. When the value of oxygen in prolyl hydroxylase
reaction was in expression of PO2 between 40 and 150 mmHg,
HIF-1a ubiquitination was nearly activated [11]. Some
researchers proposed that whether hyperoxia can used as a
powerful method to prevent the derivative change of HIF-1a
protein expression or not [12]. Although controversy existed,
hyperoxia did play a role in overcoming the primary and
secondary onset of certain types of tumors [13–15]. These factors
urge us to compare the different effects on tumor growth and
HIF-1a expression of prostate cancer (LNCaP) cell, sensitive to
androgen, under hypoxia and hyperoxia environments by
in vivo test in mice. The present study aimed to provide a new
direction for clinical treatment of prostate cancer and a
theoretical base for the research of antitumor drugs.2. Materials and methods
2.1. Cells
LNCaP cells (80%–90% conﬂuence) were cultured in RPMI-
1640 medium with 10% (V/V) heat inactivated fetal bovine
serum and L-glutamine, and cultured in 5% CO2.A
2.2. Mice
A total of 38 Foxn 1 mice, 7 wk old, about 27–30 g, were fed
and used according to the Guide for Laboratory Animals. Ani-
mal processing, training agreement and euthanasia method was
approved by Animal Processing Committee of Milan University.
Drinking water and paddling were sterilized under high tem-
perature, and feed was by irradiation at 60 C. The mice were
kept in a 12/12 h light/dark photoperiod, and can access to water
and feed until 24 h before they were sacriﬁced.2.3. Processing
On ﬁrst day, the LNCaP cells were re-suspended in the ﬁnal
concentration of 3 × 106/0.1 mL frozen agar (1:1), and inoculated
in the abdomen of mice by 26G insulin syringe. Then the mice
were transferred to the gas chamber full of mixed gas (balance
N2). According to the oxygen content, the mice were divided into:
Containing 10% O2 as Hypoxia Group (n = 12), containing 21%
O2 as Normaxia Group (n = 16), containing 30%O2 as Hyperoxia
Group (n = 10). All groups were treated for 28 d.
E
R2.4. In vivo measurement
The weight of mice and the volume of xenografts were
measured three times a week. Before measurement, the mice in
hypoxia and hyperoxia groups were transferred to complemental
gas chamber for anaerobic compensation.
R2.5. Euthanasia
On 28th day, the mice were transferred to complemental gas
chamber, anesthetized by injected sodium pentothal withheparin (500 IU) at the dose of 10 mg/100 g body weight, and
then sacriﬁced by cervical dislocation. The mice were removed
from the gas chamber and thoracotomy was performed, then the
blood sample was collected from the left ventricle. The xeno-
grafts were isolated, weighted, and stored in liquid nitrogen
at −80 C.2.6. Western blot
Prepare each biopsy extraction at 4 C. Frozen tissue (50–
80 mg) and the mixture of 10 mm HEPES, 1.5 mm magnesium
chloride, 0.5 mm DTT, 0.2 mm PMSF, 10 mm KCl and pro-
teinase inhibitor at the ratio of 1:3 (w/v) were homogenized in
glass, pH 7.9, centrifuged at 14000 r/min for 20 min and
obtained particles suspension, then centrifuged at 14000 r/min
for 10 min. The supernatant was obtained from the centrifugal
pool.
Coomassie brilliant blue kit was used to determine the pro-
tein concentration of extraction. Each electrophoresis tank, 70 g
protein was added in and separated by SDS-PAGE (6%–8%
acrylamide gel). Then, the protein was blotted on the nitrocel-
lulose membrane and sealed in the normal saline with 5% skim
milk powder and 0.1% Twin Tris buffer (room temperature, 1 h).
At 4 C, the membrane was incubated with primary antibody,
following with secondary antibody incubation marked by horse
radish peroxidase (room temperature, 1 h). Primary antibodies
and diluents adopted were: rabbit polyclonal anti-HIF-1a
(1:300), rabbit polyclonal anti-blood vessel endothelium
(1:400), mouse monoclonal anti-actin (1:10000), rabbit poly-
clonal anti-Akt (1:1000), rabbit polyclonal anti-phosphorylated
protein kinase AKT antibody-Ser473(1:1000), rabbit polyclone
anti-Nrf2(1:1000). Secondary antibody was anti-mouse IgG
(1:10000) or anti-rabbit IgG (1:10000) marked by horse radish
peroxidase. LiteAblot chemiluminescence substrate was used to
soften incubation membrane, and then chemiluminescence was
detected under the X-ray ﬁlm exposure. Gel Doc was used for
quantization of blotting intensity and the result images were
collected.
C
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D2.7. Immunoﬂuorescence
Frozen samples were embedded in OCT, and sliced contin-
uously into 5 mm thickness section with freezing microtome and
placed on the silanization glass slide. The sections were dried at
room temperature for 3 min, ﬁxed with 4% formalin for 45 min,
rinsed twice with PBS for 5 min. Then the sections were ﬁxed
with acetic acid 2:1 (v/v) for 5 min, rinsed twice with PBS for
5 min, boiled with 10 mmol/L pH 6.0 citrate buffer for 10 min,
washed once in distilled water, three times in PBS, at last in
immunoﬂuorescence.
Immunoﬂuorescence technique was employed by binding
HIF-1a, Ki67 and CD31 on one immunoﬂuorescence marked
antibody. Then mild stirred with 10% goat serum for 1 h. The
sections were processed with rabbit polyclonal anti-HIF-1a or
rabbit polyclonal anti-Ki67 (1:100), or rabbit polyclonal anti
CD31, washed with PBS at 4 C, At room temperature using
goat anti-rabbit IgG ﬂuorescent conjugated secondary antibody
treated for 45 min, washed four times with PBS, placed in pH
8.5 PBS containing 0.1% of phenylene diamine as anti-
quenching agent and glycerin (10:1). The test sample in
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substituted of anti-HIF-1a or anti-Ki67 antibody. The inverted
slide was detected under the ﬂuorescent microscope and
ﬂuorescein ﬁlter at the magniﬁcation of 40×, and the random
images were captured by CCD vidicon and stored in the
computer.
2.8. Determination of hemoglobin
Hemoglobin (Hb) concentration was determined as
following: 10 mL blood and 1 mL Drabkin's reagent were
diluted, stirred, and cultured at room temperature for 30 min,
using 1 mL test tube measured the absorbance at l = 540 nm,
calculated the concentration supposed 3= 11.05 cm−1 mM−1. Hb
content in xenografts and reference organ (left kidney) tissue
was determined by diluting 10 mL extracting solution and 1 mL
Drabkin's reagent, the following procedures as described
previously.
2.9. Statistical analysis
All data were expressed as mean ± SD. One-way ANOVA
and Dunnet multiple comparison test were used to analyze the
signiﬁcant difference among hypoxia, normoxia and hyperoxia.
The signiﬁcant level was P = 0.05 (two tailed).Figure 1. Xenografts growth in three groups.
Note: compared with normoxia group, #P < 0.05.
R
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A3. Results
3.1. General conditions of mice
In hypoxia group and hyperoxia group, each had a mouse
death before euthanasia for unknown cause. Therefore, the left
number of mice in each group was: hypoxia group 11 mice,
normoxia group 16 mice, hyperoxia group 9 mice. The increase
or inhibition of weight in each group was: hypoxia group
(0.1 ± 0.4) g, normoxia group (3.6 ± 0.7) g, hyperoxia group
(2.3 ± 0.4) g, the difference was not statistical signiﬁcant
(P > 0.05). The success rate of transplantation in each group
was: hypoxia group 68%, normoxia group 90%, hyperoxia
group 61%, the difference was not statistical signiﬁcant
(P > 0.05).
3.2. Growth of xenografts
Figure 1A shows the variation of average volume/weight of
xenografts in three groups at different time points. Xenografts
growth in hypoxia group was faster than that in normaxia, the
difference was statistically signiﬁcant (P = 0.004), while
compared with normaxia group the xenografts growth in
hyperoxia group determined at any time point showed no
statistically signiﬁcant difference (P > 0.05). Xenografts
ED
C
T
Figure 2. Comparison of the expressions of VEGF and VEGF-R2 with xenografts growth in the three groups.
Note: compared with normoxia group, #P < 0.05. TE
D
Tian-Yan Zhang et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(10): 813–820816growth in hypoxia group was twice as fast as that in normaxia
and hyperoxia groups, and compared with normaxia group, the
difference was statistical signiﬁcant (P = 0.001) (Figure 1B,
left). The weight of xenografts in hyperoxia group, comparedFigure 3. Comparison of the Hb content and vascularization of xenografts gro
Note: compared with normoxia group, #P < 0.05.
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Awith the normaxia group (Figure 1B, right), the difference was
not statistical signiﬁcant (P > 0.05); while the weight of the
xenografts in hypoxia group was signiﬁcantly higher than that
in normaxia group (P = 0.005).
Cwth in the three groups.
Figure 4. Comparison of the expression of HIF-1a with xenografts growth in the three groups.
Note: compared with normoxia group, #P < 0.05. R
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VEGF and VEGF expressions of xenografts in hyperoxia
group were signiﬁcantly higher those in normaxia group
(Figure 2) (P < 0.05); but the difference between hypoxia
group and normaxia group was not statistically signiﬁcant
difference (P > 0.05). Hb content of xenografts in hypoxia
group was signiﬁcantly higher than that in normaxia
and hyperoxia groups (Figure 3A, left) (P < 0.05). Hb
growth rate (170%) of xenografts in hypoxia group was
signiﬁcantly higher than that in hyperoxia group (40%)
(Figure 3A, medium) (P < 0.05). Compared with the Hb
content of the left kidney, Hb content of xenografts tissue in
hypoxia group was increased by 110% (Figure 3A, right).
Through the qualitative estimation of anti-CD31 immune
response of endothelial cells (Figure 3B), vascularization de-
gree of xenografts tissues in nomaxia group and hypoxia group
was quite similar, while vascularization in hyperoxia was
slightly less.
R
ET3.4. Hypoxia-inducible factors and intracellular signal
transduction
Western blot test (Figure 4A) and immunoﬂuorescence
(Figure 4B) were used to determine HIF-1a. Results showed that
the expression of HIF-1a of xenografts in hyperoxia group was
signiﬁcant increased compared with that in normaxia group
(P < 0.05). The expression of HIF-1a of xenografts in hypoxia
group and normaxia group was similar (Figure 4C). Expression
of Nrf2 of xenografts in hypoxia group was signiﬁcantly higher
than that of normoxia group (Figure 5A and C left) (P < 0.05).
Akt activity in hypoxia group was higher than that of normaxia
group and hyperoxia group, but the total expression of Akt
remained unchanged (Figure 5C, right). Fluorescent staining
based on immunohistochemical method was used to evaluate the
expression level of Ki67 (Figure 5B). Figure 5D showed that the
total number of pixel intensity, the immunoreactions of hypoxia
group was higher than that of normaxia group and hyperoxia
group.
Figure 5. Comparison of the expression of cell signaling factors in the three groups.
Note: compared with normoxia group, #P < 0.05.
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In the present study, the growth of in vivo xenografts LNCaP
cells of mice in hypoxia group was twice as fast as that in nor-
maxia group, while the xenografts growth in hyperoxia group and
normaxia group was similar. The expression level of HIF-1a in
hyperoxia group was higher than that of hypoxia group. It sug-
gested that in vivo hyperoxia can induce the growth of LNCaP cell
xenografts but did not affect the speed of xenografts growth.
Studies have reported that hyperoxia can reduce tumor growth of
rat breast tumor and gliomas by increasing cell apoptosis and
reduce vascular density [16], hyperbaric oxygen therapy can also
induce multi-differentiation and transcription of epithelial
R mesenchymal cells of low invasive tumor, thus weakened thetumor growth [17–19]. Hyperoxia had no effect on mice inoculated
PC3 prostate cancer cells [20]. The expressions of HIF-1a and
VEGF of xenografts in hyperoxia group increased, probably
because hyperoxia induced blood vessel contraction and blood
ﬂew volume decreased, thus caused regional hypoxia.
4.1. Hypoxia-inducible factor
HIF-1a plays a key role in the development of malignant
tumors including prostate cancer, and the up-regulation of HIF-
1a manifests early prostate cancer and cancer development
promoting angiogenesis [21]. Researches had shown that in
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failed to show the signiﬁcant antitumor effect [22]; when
LNCaP cells were acute hypoxia, HIF-1a had a high
expression, with time course, HIF-1a returned to normal or
even low expression level [23]. Therefore, antitumor therapy
only counted on HIF-1a inhibitors may be invalid. In the
present study the growth rate of xenografts is inversely
proportional to the increase of HIF-1a expression, which
suggested that the expression of HIF-1a doesn't play a
decisive role in the growth mode of xenografts. The hyperoxia
test provides a possibility to study the related mechanism of
HIF-1a in the signal pathway of tumor growth.4.2. Angiogenesis
VEGF/VEGF-R2 signal pathway was recognized as the most
prominent way for tumor promotion [24]. Hypoxia can slightly
induced VEGF-R2, while hyperoxia can adjust VEGF and
VEGF-R2 at a larger extent through stimulating the expression
of HIF-1a, thus increase the pathway of activated VEGF/
VEGF-R2 [25]. However, the increased activity of VEGF/
VEGF-R2 signal pathway has no relation with the increased
Hb content of xenografts. Therefore, in the results of present
study VEGF and VEGF-R2 of xenografts in hyperoxia group
has high expressions, while the Hb content is lower than that of
hypoxia group. Slight vascularization in hyperoxia group
observed may caused by hyperoxia induced vasoconstriction,
thus reduce angiogenesis.A
4.3. Signal pathway
Akt activation is the sign of cells survival under hypoxia
environment [26]. The activity of Akt in hypoxia group is
higher than that of normaxia group and hyperoxia group. It
suggested that the faster growth of hypoxia-inducible xeno-
grafts in prostate cancer cell has a certain relation with the
increased activation of Akt. Nrf2 protein is a transcription
factor which can activate antioxidant reaction [27], and
regarded as a tumor suppressor for its ability to remove
cellular environmental toxicity [28]. In the results, the
expression level of Nrf2 in hyperoxia was signiﬁcantly
higher which showed hyperoxic cells has a strong
antioxidant response ability, thus suggested hyperoxia make
the in vivo redox reaction out of balance.
Hyperoxia in pulmonary epithelial cells can stimulate Nrf2
transcriptional response by PI3K/Akt signa [29]. In the preset
study, the overexpression of Nrf2 of xenografts in hyperoxia
group is not consistent with the high expression of Akt of
xenografts in hypoxia group. This may caused by the role of
ROS at two different phases [30], i.e. ROS as Akt activation in
low expression (such as hypoxia), while in high expression the
toxic effects turn into advantages (such as hyperoxia), leading
to Akt inactivation.
In conclusion, hyperoxia can induce the overexpression of
HIF-1a in LNCaP cells without affecting the xenografts growth
rate, and diminish in vivo hypoxia and angiogenic signaling by
unbalancing in vivo hyperoxia redox reaction and the complex
interaction of cell proliferation pathways. The present study
provides a new idea for the clinical treatment of prostate cancer
and the future research on the basic features of hyperoxia
affecting the process of tumor will be of great signiﬁcance.
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